Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Summit Therapeutics (SMMT)
Technical Analysis Report for USA stock SMMT Summit Therapeutics. Dated: 12 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SMMT Summit Therapeutics then click here. or read Experts views on Summit Therapeutics or Forecast & share price targets of Summit Therapeutics
Summit Therapeutics Opened at 17.97 and Closed at: 17.57, which is -2.39% of previous session's close. It moved within a range of 17.39 and 18.03
The session was a Bearish session with an average volume of 1591100, which is -3.61% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
A Golden cross was found 5 days back on short term averages
Support for tomorrow is 17.16 and resistance for tomorrow is 17.8
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 17.3, 17.02 resistance for tomorrow's hourly charts is 17.94, 18.3
10 Day SMA for Summit Therapeutics (SMMT) is 17.92 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Summit Therapeutics (SMMT) is 17.57 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Summit Therapeutics (SMMT) is 19.03 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 21.37 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Summit Therapeutics is 21.93 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Summit Therapeutics is at 17.57 and 200 DMA is at 21.93, while 50 DMA and 100 DMA are at 19.03 and 21.37 respectively
Summit Therapeutics (SMMT) moving average of 20 SMA is at 17.57 and 20 EMA is at 17.91
| Date | Closing Price | 20 SMA | 20 EMA |
| 12 Fri Dec | 17.57 | 17.57 | 17.91 |
| 11 Thu Dec | 17.99 | 17.6 | 17.95 |
| 10 Wed Dec | 17.94 | 17.64 | 17.95 |
| 09 Tue Dec | 17.02 | 17.7 | 17.95 |
| 08 Mon Dec | 18.63 | 17.77 | 18.05 |
| 05 Fri Dec | 18.31 | 17.75 | 17.99 |
Summit Therapeutics (SMMT) moving average of 50 SMA is at 19.03 and 50 EMA is at 18.87
| Date | Closing Price | 50 SMA | 50 EMA |
| 12 Fri Dec | 17.57 | 19.03 | 18.87 |
| 11 Thu Dec | 17.99 | 19.09 | 18.92 |
| 10 Wed Dec | 17.94 | 19.14 | 18.96 |
| 09 Tue Dec | 17.02 | 19.2 | 19 |
| 08 Mon Dec | 18.63 | 19.28 | 19.08 |
| 05 Fri Dec | 18.31 | 19.33 | 19.1 |
Summit Therapeutics (SMMT) moving average of 100 SMA is at 21.37 and 100 EMA is at 20.12
| Date | Closing Price | 100 SMA | 100 EMA |
| 12 Fri Dec | 17.57 | 21.37 | 20.12 |
| 11 Thu Dec | 17.99 | 21.47 | 20.17 |
| 10 Wed Dec | 17.94 | 21.56 | 20.21 |
| 09 Tue Dec | 17.02 | 21.64 | 20.26 |
| 08 Mon Dec | 18.63 | 21.73 | 20.33 |
| 05 Fri Dec | 18.31 | 21.82 | 20.36 |
Summit Therapeutics (SMMT) moving average of 200 SMA is at 21.93 and 200 EMA is at 20.37
| Date | Closing Price | 200 SMA | 200 EMA |
| 12 Fri Dec | 17.57 | 21.93 | 20.37 |
| 11 Thu Dec | 17.99 | 21.93 | 20.4 |
| 10 Wed Dec | 17.94 | 21.94 | 20.42 |
| 09 Tue Dec | 17.02 | 21.94 | 20.45 |
| 08 Mon Dec | 18.63 | 21.95 | 20.48 |
| 05 Fri Dec | 18.31 | 21.96 | 20.5 |
Davita Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Davita Inc, about 2.39% more returns!
Bristol Myers has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Bristol Myers, about 14.9% more returns!
Summit Therapeutics has performed better than Xtl Biopharmaceuticals in short term. Holding Summit Therapeutics could be a better choice for now!
Dentsply Sirona has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Dentsply Sirona, about 12.53% more returns!
Xenon Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Xenon Pharmaceuticals, about 10.65% more returns!
Soligenix Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Soligenix Inc, about 22.99% more returns!
Repligen Corporation has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Repligen Corporation, about 5.84% more returns!
Ptc Therapeutics has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Ptc Therapeutics, about 3% more returns!
Summit Therapeutics has performed better than Ligand Pharmaceuticals in short term. Holding Summit Therapeutics could be a better choice for now!
Inovio Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Inovio Pharmaceuticals, about 3.04% more returns!
Eton Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 1.13% more returns!
Summit Therapeutics has performed better than Editas Medicine in short term. Holding Summit Therapeutics could be a better choice for now!
Cidara Therapeutics has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Cidara Therapeutics, about 3.9% more returns!
Beyondspring Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Beyondspring Inc, about 3.51% more returns!
Summit Therapeutics has performed better than Audentes Therapeutics in short term. Holding Summit Therapeutics could be a better choice for now!
Apyx Medical has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 1.52% more returns!
Apellis Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Apellis Pharmaceuticals, about 26.65% more returns!
Summit Therapeutics Technical analysis of indicators
Price action analysis of Summit Therapeutics (SMMT) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Summit Therapeutics in short term but the buy signal is initial and weak.
Summit Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Summit Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Summit Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 17.91 and Summit Therapeutics SMMT stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Summit Therapeutics SMMT stock. Volume based technical analysis of Summit Therapeutics SMMT stock is negative.
Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SMMT Summit Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SMMT Experts View which covers a lot of information including buying and selling signals
SMMT future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Summit Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


